These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 3910169)
1. Brain dopamine activity following intranigral or intrathalamic drug injections in the rat. Kilpatrick IC; Starr MS; Summerhayes M Brain Res Bull; 1985 Dec; 15(6):553-61. PubMed ID: 3910169 [TBL] [Abstract][Full Text] [Related]
2. Role of the ventromedial nucleus of the thalamus in motor behaviour--I. Effects of focal injections of drugs. Starr MS; Summerhayes M Neuroscience; 1983 Dec; 10(4):1157-69. PubMed ID: 6320046 [TBL] [Abstract][Full Text] [Related]
3. Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the inhibitory GABAA receptor agonist muscimol. Savaki HE; Raos VC; Dermon CR Neuroscience; 1992 Oct; 50(4):781-94. PubMed ID: 1333060 [TBL] [Abstract][Full Text] [Related]
4. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--II. Studies using ibotenic acid injection of the parafascicular-intralaminar nuclei. Kilpatrick IC; Jones MW; Johnson BJ; Cornwall J; Phillipson OT Neuroscience; 1986 Nov; 19(3):979-90. PubMed ID: 3796824 [TBL] [Abstract][Full Text] [Related]
5. Role of the ventromedial nucleus of the thalamus in motor behaviour--II. Effects of lesions. Starr MS; Summerhayes M Neuroscience; 1983 Dec; 10(4):1171-83. PubMed ID: 6320047 [TBL] [Abstract][Full Text] [Related]
6. Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the putative excitatory neurotransmitter substance P. Dermon CR; Tzagournissakis M; Savaki HE Neuroscience; 1992 Oct; 50(4):795-809. PubMed ID: 1280349 [TBL] [Abstract][Full Text] [Related]
7. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Sirinathsinghji DJ; Whittington PE; Audsley AR Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361 [TBL] [Abstract][Full Text] [Related]
8. Motor effects following application of putative excitatory amino acid antagonists to the region of the mesencephalic dopamine cell bodies in the rat. Dawbarn D; Pycock CJ Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):100-4. PubMed ID: 6120471 [TBL] [Abstract][Full Text] [Related]
9. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--I. The influence of electrical stimulation of the parafascicular nucleus on dopamine utilization. Kilpatrick IC; Phillipson OT Neuroscience; 1986 Nov; 19(3):965-78. PubMed ID: 3796823 [TBL] [Abstract][Full Text] [Related]
10. GABAA receptors in the mediodorsal thalamus play a crucial role in rat shell-specific acetylcholine-mediated, but not dopamine-mediated, turning behaviour. Ikeda H; Kotani A; Lee J; Koshikawa N; Cools AR Neuroscience; 2009 Apr; 159(4):1200-7. PubMed ID: 19217930 [TBL] [Abstract][Full Text] [Related]
12. Circling behavior induced by intranigral injections of GABA and muscimol in rats. Kaakkola S; Kääriäinen I Psychopharmacology (Berl); 1980; 68(1):31-6. PubMed ID: 6771796 [TBL] [Abstract][Full Text] [Related]
13. Involvement of dopamine in circling responses to muscimol depends on intranigral site of injection. Kilpatrick IC; Starr MS Eur J Pharmacol; 1981 Feb; 69(4):407-19. PubMed ID: 6265225 [TBL] [Abstract][Full Text] [Related]
14. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Zhang Y; Loonam TM; Noailles PA; Angulo JA Ann N Y Acad Sci; 2001 Jun; 937():93-120. PubMed ID: 11458542 [TBL] [Abstract][Full Text] [Related]
15. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion. Sirinathsinghji DJ; Heavens RP; Richards SJ; Beresford IJ; Hall MD Neuroscience; 1988 Oct; 27(1):117-28. PubMed ID: 3264391 [TBL] [Abstract][Full Text] [Related]
16. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat. Ford AP; Marsden CA Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584 [TBL] [Abstract][Full Text] [Related]
17. Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats. Martin D; Miller G; Cullen T; Fischer N; Dix D; Russell D Eur J Pharmacol; 1996 Dec; 317(2-3):247-56. PubMed ID: 8997607 [TBL] [Abstract][Full Text] [Related]
18. Involvement of the nigral output pathways in the inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat. Depaulis A; Vergnes M; Liu Z; Kempf E; Marescaux C Neuroscience; 1990; 39(2):339-49. PubMed ID: 2128373 [TBL] [Abstract][Full Text] [Related]
19. Circling behavior following unilateral kainic acid injections into rat striatum. Taylor RJ; Reavill C; Jenner P; Marsden CD Eur J Pharmacol; 1981 Dec; 76(2-3):211-22. PubMed ID: 7333356 [TBL] [Abstract][Full Text] [Related]
20. Evidence for a GABAergic nigrothalamic pathway in the rat. I. Behavioural and biochemical studies. Kilpatrick IC; Starr MS; Fletcher A; James TA; MacLeod NK Exp Brain Res; 1980; 40(1):45-54. PubMed ID: 6252029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]